Christopher Morris
Physician Assistant · Mesa, AZNPI 1366451007
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $693 and has fallen 81.8% since, to $126 in 2025.
Across 67 payments — averaging $20.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$259
- AbbVie$201
- Coloplast$149
- Merz North America, Inc.$140
- Hollister Incorporated$109
- 180 Medical, Inc.$88
- plus $402 from 18 others
What the payments were for
- Food & beverage$1,29696%
- Education$524%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 11 | $259 |
| AbbVie(2 entities) | 10 | $201 |
| Coloplast | 16 | $149 |
| Merz North America, Inc. | 1 | $140 |
| Hollister Incorporated | 3 | $109 |
| 180 Medical, Inc. | 4 | $88 |
| Myovant Sciences Inc. | 3 | $58 |
| Abbott | 2 | $39 |
| Rochester Medical Corporation | 2 | $34 |
| Procept Biorobotics Corporation | 1 | $27 |
| BD | 1 | $27 |
| Teleflex LLC | 1 | $23 |
| Smith+Nephew | 1 | $23 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| Boston Scientific | 1 | $18 |
| Heron Therapeutics, Inc. | 1 | $18 |
| Axonics, Inc. | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $16 |
| Clarus Therapeutics Inc. | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| Convatec Inc. | 1 | $14 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $12 |
| Galderma Laboratories, L.p. | 1 | $12 |
| Sagent Pharmaceuticals | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$140
How this compares
$1,348 in reported general payments places this provider in the 75th percentile of 2,888 physician assistant providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 11 | $10,802 |
| Anastrozole | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Mesa
- Jessica RosenblumMesa$19K
- Katrina McDanielMesa$14K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
- Nicole StokerTucson$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.